Zhixin Finance and Economics APP News, Weigao Group (01066) announced the performance of Weigao Orthopedics (688161.SH) in the third quarter of 2024, with a revenue of approximately 0.333 billion yuan, a year-on-year increase of 20.06%; net income attributable to shareholders of the listed company is approximately 71.1633 million yuan, a year-on-year increase of 5.94 times; basic earnings per share is 0.18 yuan.

From January to September, revenue is approximately 1.083 billion yuan, a year-on-year increase of 0.07%; net income attributable to shareholders of the listed company is approximately 0.164 billion yuan, a year-on-year increase of 34.66%; basic earnings per share is 0.41 yuan.

The announcement stated that the main reason for the increase in net profit in the third quarter is the increase in sales volume compared to the same period last year, leading to an increase in sales profit; at the same time, business service fees in the reporting period decreased compared to the same period last year, resulting in a reduction in sales expenses, which collectively led to an increase in net income attributable to shareholders of the listed company for this reporting period.